What is CVE-2018-18977?

CVE-2018-18977 is a high-severity vulnerability in Ascensia Contour Diabetes, classified under Information Disclosure. CVSS score: 7.5/10. Published 2019-05-06.

How severe is CVE-2018-18977?

High severity. CVSS v3 base score is 7.5 out of 10.

Information disclosure in Ascensia Contour Diabetes

CVE-2018-18977

An issue was discovered in the Ascensia Contour NEXT ONE application for Android before 2019-01-15. An attacker may reverse engineer the codebase to extract sensitive data that contributes to the disclosure of medical information of patients utilizing the Ascensia platform. This occurs because of weak obfuscation.

Vulnerability class: Information Disclosure

EPSS: 0.016 (73.0th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.

Affected products

Ascensia Contour_diabetes
N/a — versions n/a

Weakness classification (CWE)

CWE-200 — Information Disclosure

References

cve@mitre.org (Exploit, Third Party Advisory, x_refsource_MISC)

Frequently asked questions

What is CVE-2018-18977?: CVE-2018-18977 is a high-severity vulnerability in Ascensia Contour Diabetes, classified under Information Disclosure. CVSS score: 7.5/10. Published 2019-05-06.
How severe is CVE-2018-18977?: High severity. CVSS v3 base score is 7.5 out of 10.